|COUNTRY OF ORIGIN||India|
|DOSAGE FORM||Extended Release Tablets|
|MANUFACTURER||Sun Pharmaceutical Industries Ltd|
|PACKAGING||10 tablets in 1 strip|
|PACK SIZE||100 Tablet/s, 200 Tablet/s, 300 Tablet/s 500 Tablet/s|
Bupron XL 300 Tablet is used in the treatment of depression and smoking addiction. This medicine helps by increasing the level of chemical messengers in the brain that relax the nerves and have a calming effect on the brain.
Bupron XL 300 Tablet may be taken with or without food. It is advised to take this medicine at a fixed time each day. You should never skip any doses and finish the full course of treatment even if you feel better. This medication mustn’t be stopped suddenly as it may worsen your symptoms.
Some common side effects of this medicine include insomnia (difficulty sleeping), allergic reaction, impaired concentration, sweating, headache, nausea, vomiting, and dry mouth. It even causes dizziness and sleepiness, so do not drive or do anything that requires mental focus. Moreover, most of the side effects are immediate and often go away with time. Please consult your doctor if these bother you or do not go away.
Before taking this medicine it is important to inform your doctor if you have any history of seizure or if you drink alcohol. Inform your doctor if you develop any unusual mood changes or if you have any suicidal thoughts.
USES OF BUPRON TABLET PR
- Smoking addiction
BENEFITS OF BUPRON TABLET PR
SIDE EFFECTS OF BUPRON TABLET PR
Common side effects of Bupron
- Insomnia (difficulty in sleeping)
- Allergic reaction
- Impaired concentration
- Dryness in mouth
- Taste change
- Abdominal pain
HOW TO USE BUPRON TABLET PR
HOW BUPRON TABLET PR WORKS
Bupron XL 300 Tablet may cause dizziness or light-headedness, may affect your concentration and judgement. This may affect your driving ability.
Caution is advised for the use of Bupron XL 300 Tablet in these patients with close monitoring from a doctor for any possible side effects.
WHAT IF YOU FORGET TO TAKE BUPRON TABLET PR?
There are no reviews yet.